News

Penthrox: USA update

Aug 29, 2018Cathy WilsonNews

29 August 2018

ASX Announcement

Penthrox: USA update

Medical Developments International Limited (ASX: MVP) advise that it has received correspondence from the USA Food & Drug Administration (?FDA?) in relation to its Investigative New Drug (?IND?) application to have Penthrox approved for sale in the United States of America.

For the full release, please click on the link:?Penthrox USA Update

'),document.contains||document.write(''),window.DOMRect||document.write(''),window.URL&&window.URL.prototype&&window.URLSearchParams||document.write(''),window.FormData&&window.FormData.prototype.keys||document.write(''),Element.prototype.matches&&Element.prototype.closest||document.write('')